334
Views
4
CrossRef citations to date
0
Altmetric
Review

Treating brain metastases in non-small cell lung cancer patients: what have we learnt from pharmaceutical recent clinical trials?

ORCID Icon, &
Pages 851-864 | Received 21 Jan 2018, Accepted 01 May 2018, Published online: 22 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Muhammad Khan, Zhihong Zhao, Xianming Li & Guixiang Liao. (2021) Anti-PD1 Therapy Plus Whole-Brain Radiation Therapy May Prolong PFS in Selected Non–Small Cell Lung Cancer Patients with Brain Metastases: A Retrospective Study. International Journal of General Medicine 14, pages 8903-8918.
Read now

Articles from other publishers (3)

Guixiang Liao, Yuting Qian, Sumbal Arooj, Zhihong Zhao, Maosheng Yan, Zihuang Li, Hongli Yang, Tao Zheng, Gang Li, Xianming Li & Muhammad Khan. (2021) Radiation Plus Anti-PD-1 Therapy for NSCLC Brain Metastases: A Retrospective Study. Frontiers in Oncology 11.
Crossref
Xingjiang Hu, Hui Yu, Yunliang Zheng, Qiao Zhang, Meihua Lin, Jialei Wang & Yunqing Qiu. (2020) Immune Checkpoint Inhibitors and Survival Outcomes in Brain Metastasis: A Time Series-Based Meta-Analysis. Frontiers in Oncology 10.
Crossref
Wang Li & Hong Yu. (2019) Separating or combining immune checkpoint inhibitors (ICIs) and radiotherapy in the treatment of NSCLC brain metastases. Journal of Cancer Research and Clinical Oncology 146:1, pages 137-152.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.